- Home
- YETI vs DNLI Comparison
YETI vs DNLI Comparison
Compare YETI & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YETI | DNLI |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.4B |
| IPO Year | 2016 | 2017 |
Fundamental Metrics
Financial Performance| Metric | YETI | DNLI |
|---|---|---|
| Price | $44.10 | $18.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 20 |
| Target Price | ★ $54.31 | $35.75 |
| AVG Volume (30 Days) | 1.3M | ★ 1.8M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $1,868,494,000.00 | N/A |
| Revenue This Year | $7.63 | N/A |
| Revenue Next Year | $7.07 | $158.26 |
| P/E Ratio | $40.41 | ★ N/A |
| Revenue Growth | ★ 2.11 | N/A |
| 52 Week Low | $32.26 | $13.75 |
| 52 Week High | $53.99 | $27.30 |
Technical Indicators
Market Signals| Indicator | YETI | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 61.05 | 41.65 |
| Support Level | $43.55 | $18.07 |
| Resistance Level | $44.10 | $20.84 |
| Average True Range (ATR) | 1.16 | 0.82 |
| MACD | 0.47 | 0.09 |
| Stochastic Oscillator | 96.26 | 47.64 |
Price Performance
Historical ComparisonAbout YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.